<?xml version="1.0" encoding="UTF-8"  standalone="no" ?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2004-03-29" modified="2024-10-02" version="179" xmlns="http://uniprot.org/uniprot">
  <accession>Q8IUX4</accession>
  <accession>B0QYD4</accession>
  <accession>Q45F03</accession>
  <accession>Q6ICH3</accession>
  <accession>Q7Z2N2</accession>
  <accession>Q7Z2N5</accession>
  <name>ABC3F_HUMAN</name>
  <protein>
    <recommendedName>
      <fullName evidence="32">DNA dC-&gt;dU-editing enzyme APOBEC-3F</fullName>
      <ecNumber evidence="10">3.5.4.38</ecNumber>
    </recommendedName>
    <alternativeName>
      <fullName>Apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3F</fullName>
      <shortName evidence="31">A3F</shortName>
    </alternativeName>
  </protein>
  <gene>
    <name evidence="28 34" type="primary">APOBEC3F</name>
  </gene>
  <organism>
    <name type="scientific">Homo sapiens</name>
    <name type="common">Human</name>
    <dbReference type="NCBI Taxonomy" id="9606"/>
    <lineage>
      <taxon>Eukaryota</taxon>
      <taxon>Metazoa</taxon>
      <taxon>Chordata</taxon>
      <taxon>Craniata</taxon>
      <taxon>Vertebrata</taxon>
      <taxon>Euteleostomi</taxon>
      <taxon>Mammalia</taxon>
      <taxon>Eutheria</taxon>
      <taxon>Euarchontoglires</taxon>
      <taxon>Primates</taxon>
      <taxon>Haplorrhini</taxon>
      <taxon>Catarrhini</taxon>
      <taxon>Hominidae</taxon>
      <taxon>Homo</taxon>
    </lineage>
  </organism>
  <reference key="1">
    <citation type="journal article" date="2004" name="Genome Biol." volume="5" first="R84.1" last="R84.11">
      <title>A genome annotation-driven approach to cloning the human ORFeome.</title>
      <authorList>
        <person name="Collins J.E."/>
        <person name="Wright C.L."/>
        <person name="Edwards C.A."/>
        <person name="Davis M.P."/>
        <person name="Grinham J.A."/>
        <person name="Cole C.G."/>
        <person name="Goward M.E."/>
        <person name="Aguado B."/>
        <person name="Mallya M."/>
        <person name="Mokrab Y."/>
        <person name="Huckle E.J."/>
        <person name="Beare D.M."/>
        <person name="Dunham I."/>
      </authorList>
      <dbReference type="PubMed" id="15461802"/>
      <dbReference type="DOI" id="10.1186/gb-2004-5-10-r84"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3)</scope>
  </reference>
  <reference key="2">
    <citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
      <authorList>
        <consortium name="SeattleSNPs variation discovery resource"/>
      </authorList>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1)</scope>
    <scope>VARIANTS THR-178; ILE-231 AND CYS-307</scope>
  </reference>
  <reference key="3">
    <citation type="journal article" date="1999" name="Nature" volume="402" first="489" last="495">
      <title>The DNA sequence of human chromosome 22.</title>
      <authorList>
        <person name="Dunham I."/>
        <person name="Hunt A.R."/>
        <person name="Collins J.E."/>
        <person name="Bruskiewich R."/>
        <person name="Beare D.M."/>
        <person name="Clamp M."/>
        <person name="Smink L.J."/>
        <person name="Ainscough R."/>
        <person name="Almeida J.P."/>
        <person name="Babbage A.K."/>
        <person name="Bagguley C."/>
        <person name="Bailey J."/>
        <person name="Barlow K.F."/>
        <person name="Bates K.N."/>
        <person name="Beasley O.P."/>
        <person name="Bird C.P."/>
        <person name="Blakey S.E."/>
        <person name="Bridgeman A.M."/>
        <person name="Buck D."/>
        <person name="Burgess J."/>
        <person name="Burrill W.D."/>
        <person name="Burton J."/>
        <person name="Carder C."/>
        <person name="Carter N.P."/>
        <person name="Chen Y."/>
        <person name="Clark G."/>
        <person name="Clegg S.M."/>
        <person name="Cobley V.E."/>
        <person name="Cole C.G."/>
        <person name="Collier R.E."/>
        <person name="Connor R."/>
        <person name="Conroy D."/>
        <person name="Corby N.R."/>
        <person name="Coville G.J."/>
        <person name="Cox A.V."/>
        <person name="Davis J."/>
        <person name="Dawson E."/>
        <person name="Dhami P.D."/>
        <person name="Dockree C."/>
        <person name="Dodsworth S.J."/>
        <person name="Durbin R.M."/>
        <person name="Ellington A.G."/>
        <person name="Evans K.L."/>
        <person name="Fey J.M."/>
        <person name="Fleming K."/>
        <person name="French L."/>
        <person name="Garner A.A."/>
        <person name="Gilbert J.G.R."/>
        <person name="Goward M.E."/>
        <person name="Grafham D.V."/>
        <person name="Griffiths M.N.D."/>
        <person name="Hall C."/>
        <person name="Hall R.E."/>
        <person name="Hall-Tamlyn G."/>
        <person name="Heathcott R.W."/>
        <person name="Ho S."/>
        <person name="Holmes S."/>
        <person name="Hunt S.E."/>
        <person name="Jones M.C."/>
        <person name="Kershaw J."/>
        <person name="Kimberley A.M."/>
        <person name="King A."/>
        <person name="Laird G.K."/>
        <person name="Langford C.F."/>
        <person name="Leversha M.A."/>
        <person name="Lloyd C."/>
        <person name="Lloyd D.M."/>
        <person name="Martyn I.D."/>
        <person name="Mashreghi-Mohammadi M."/>
        <person name="Matthews L.H."/>
        <person name="Mccann O.T."/>
        <person name="Mcclay J."/>
        <person name="Mclaren S."/>
        <person name="McMurray A.A."/>
        <person name="Milne S.A."/>
        <person name="Mortimore B.J."/>
        <person name="Odell C.N."/>
        <person name="Pavitt R."/>
        <person name="Pearce A.V."/>
        <person name="Pearson D."/>
        <person name="Phillimore B.J.C.T."/>
        <person name="Phillips S.H."/>
        <person name="Plumb R.W."/>
        <person name="Ramsay H."/>
        <person name="Ramsey Y."/>
        <person name="Rogers L."/>
        <person name="Ross M.T."/>
        <person name="Scott C.E."/>
        <person name="Sehra H.K."/>
        <person name="Skuce C.D."/>
        <person name="Smalley S."/>
        <person name="Smith M.L."/>
        <person name="Soderlund C."/>
        <person name="Spragon L."/>
        <person name="Steward C.A."/>
        <person name="Sulston J.E."/>
        <person name="Swann R.M."/>
        <person name="Vaudin M."/>
        <person name="Wall M."/>
        <person name="Wallis J.M."/>
        <person name="Whiteley M.N."/>
        <person name="Willey D.L."/>
        <person name="Williams L."/>
        <person name="Williams S.A."/>
        <person name="Williamson H."/>
        <person name="Wilmer T.E."/>
        <person name="Wilming L."/>
        <person name="Wright C.L."/>
        <person name="Hubbard T."/>
        <person name="Bentley D.R."/>
        <person name="Beck S."/>
        <person name="Rogers J."/>
        <person name="Shimizu N."/>
        <person name="Minoshima S."/>
        <person name="Kawasaki K."/>
        <person name="Sasaki T."/>
        <person name="Asakawa S."/>
        <person name="Kudoh J."/>
        <person name="Shintani A."/>
        <person name="Shibuya K."/>
        <person name="Yoshizaki Y."/>
        <person name="Aoki N."/>
        <person name="Mitsuyama S."/>
        <person name="Roe B.A."/>
        <person name="Chen F."/>
        <person name="Chu L."/>
        <person name="Crabtree J."/>
        <person name="Deschamps S."/>
        <person name="Do A."/>
        <person name="Do T."/>
        <person name="Dorman A."/>
        <person name="Fang F."/>
        <person name="Fu Y."/>
        <person name="Hu P."/>
        <person name="Hua A."/>
        <person name="Kenton S."/>
        <person name="Lai H."/>
        <person name="Lao H.I."/>
        <person name="Lewis J."/>
        <person name="Lewis S."/>
        <person name="Lin S.-P."/>
        <person name="Loh P."/>
        <person name="Malaj E."/>
        <person name="Nguyen T."/>
        <person name="Pan H."/>
        <person name="Phan S."/>
        <person name="Qi S."/>
        <person name="Qian Y."/>
        <person name="Ray L."/>
        <person name="Ren Q."/>
        <person name="Shaull S."/>
        <person name="Sloan D."/>
        <person name="Song L."/>
        <person name="Wang Q."/>
        <person name="Wang Y."/>
        <person name="Wang Z."/>
        <person name="White J."/>
        <person name="Willingham D."/>
        <person name="Wu H."/>
        <person name="Yao Z."/>
        <person name="Zhan M."/>
        <person name="Zhang G."/>
        <person name="Chissoe S."/>
        <person name="Murray J."/>
        <person name="Miller N."/>
        <person name="Minx P."/>
        <person name="Fulton R."/>
        <person name="Johnson D."/>
        <person name="Bemis G."/>
        <person name="Bentley D."/>
        <person name="Bradshaw H."/>
        <person name="Bourne S."/>
        <person name="Cordes M."/>
        <person name="Du Z."/>
        <person name="Fulton L."/>
        <person name="Goela D."/>
        <person name="Graves T."/>
        <person name="Hawkins J."/>
        <person name="Hinds K."/>
        <person name="Kemp K."/>
        <person name="Latreille P."/>
        <person name="Layman D."/>
        <person name="Ozersky P."/>
        <person name="Rohlfing T."/>
        <person name="Scheet P."/>
        <person name="Walker C."/>
        <person name="Wamsley A."/>
        <person name="Wohldmann P."/>
        <person name="Pepin K."/>
        <person name="Nelson J."/>
        <person name="Korf I."/>
        <person name="Bedell J.A."/>
        <person name="Hillier L.W."/>
        <person name="Mardis E."/>
        <person name="Waterston R."/>
        <person name="Wilson R."/>
        <person name="Emanuel B.S."/>
        <person name="Shaikh T."/>
        <person name="Kurahashi H."/>
        <person name="Saitta S."/>
        <person name="Budarf M.L."/>
        <person name="McDermid H.E."/>
        <person name="Johnson A."/>
        <person name="Wong A.C.C."/>
        <person name="Morrow B.E."/>
        <person name="Edelmann L."/>
        <person name="Kim U.J."/>
        <person name="Shizuya H."/>
        <person name="Simon M.I."/>
        <person name="Dumanski J.P."/>
        <person name="Peyrard M."/>
        <person name="Kedra D."/>
        <person name="Seroussi E."/>
        <person name="Fransson I."/>
        <person name="Tapia I."/>
        <person name="Bruder C.E."/>
        <person name="O'Brien K.P."/>
        <person name="Wilkinson P."/>
        <person name="Bodenteich A."/>
        <person name="Hartman K."/>
        <person name="Hu X."/>
        <person name="Khan A.S."/>
        <person name="Lane L."/>
        <person name="Tilahun Y."/>
        <person name="Wright H."/>
      </authorList>
      <dbReference type="PubMed" id="10591208"/>
      <dbReference type="DOI" id="10.1038/990031"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
  </reference>
  <reference key="4">
    <citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
      <authorList>
        <person name="Mural R.J."/>
        <person name="Istrail S."/>
        <person name="Sutton G.G."/>
        <person name="Florea L."/>
        <person name="Halpern A.L."/>
        <person name="Mobarry C.M."/>
        <person name="Lippert R."/>
        <person name="Walenz B."/>
        <person name="Shatkay H."/>
        <person name="Dew I."/>
        <person name="Miller J.R."/>
        <person name="Flanigan M.J."/>
        <person name="Edwards N.J."/>
        <person name="Bolanos R."/>
        <person name="Fasulo D."/>
        <person name="Halldorsson B.V."/>
        <person name="Hannenhalli S."/>
        <person name="Turner R."/>
        <person name="Yooseph S."/>
        <person name="Lu F."/>
        <person name="Nusskern D.R."/>
        <person name="Shue B.C."/>
        <person name="Zheng X.H."/>
        <person name="Zhong F."/>
        <person name="Delcher A.L."/>
        <person name="Huson D.H."/>
        <person name="Kravitz S.A."/>
        <person name="Mouchard L."/>
        <person name="Reinert K."/>
        <person name="Remington K.A."/>
        <person name="Clark A.G."/>
        <person name="Waterman M.S."/>
        <person name="Eichler E.E."/>
        <person name="Adams M.D."/>
        <person name="Hunkapiller M.W."/>
        <person name="Myers E.W."/>
        <person name="Venter J.C."/>
      </authorList>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
  </reference>
  <reference key="5">
    <citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
      <title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
      <authorList>
        <consortium name="The MGC Project Team"/>
      </authorList>
      <dbReference type="PubMed" id="15489334"/>
      <dbReference type="DOI" id="10.1101/gr.2596504"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2)</scope>
    <scope>VARIANTS PRO-48 AND SER-108</scope>
    <source>
      <tissue>Pancreas</tissue>
      <tissue>Spleen</tissue>
      <tissue>Uterus</tissue>
    </source>
  </reference>
  <reference key="6">
    <citation type="journal article" date="2002" name="Genomics" volume="79" first="285" last="296">
      <title>An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22.</title>
      <authorList>
        <person name="Jarmuz A."/>
        <person name="Chester A."/>
        <person name="Bayliss J."/>
        <person name="Gisbourne J."/>
        <person name="Dunham I."/>
        <person name="Scott J."/>
        <person name="Navaratnam N."/>
      </authorList>
      <dbReference type="PubMed" id="11863358"/>
      <dbReference type="DOI" id="10.1006/geno.2002.6718"/>
    </citation>
    <scope>GENE FAMILY ORGANIZATION</scope>
    <scope>TISSUE SPECIFICITY</scope>
  </reference>
  <reference key="7">
    <citation type="journal article" date="2003" name="Trends Genet." volume="19" first="207" last="216">
      <title>Messenger RNA editing in mammals: new members of the APOBEC family seeking roles in the family business.</title>
      <authorList>
        <person name="Wedekind J.E."/>
        <person name="Dance G.S.C."/>
        <person name="Sowden M.P."/>
        <person name="Smith H.C."/>
      </authorList>
      <dbReference type="PubMed" id="12683974"/>
      <dbReference type="DOI" id="10.1016/s0168-9525(03)00054-4"/>
    </citation>
    <scope>REVIEW ON APOBEC FAMILIES</scope>
  </reference>
  <reference key="8">
    <citation type="journal article" date="2004" name="J. Virol." volume="78" first="6073" last="6076">
      <title>Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication.</title>
      <authorList>
        <person name="Zheng Y.H."/>
        <person name="Irwin D."/>
        <person name="Kurosu T."/>
        <person name="Tokunaga K."/>
        <person name="Sata T."/>
        <person name="Peterlin B.M."/>
      </authorList>
      <dbReference type="PubMed" id="15141007"/>
      <dbReference type="DOI" id="10.1128/jvi.78.11.6073-6076.2004"/>
    </citation>
    <scope>FUNCTION</scope>
  </reference>
  <reference key="9">
    <citation type="journal article" date="2004" name="EMBO J." volume="23" first="2451" last="2458">
      <title>A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins.</title>
      <authorList>
        <person name="Wiegand H.L."/>
        <person name="Doehle B.P."/>
        <person name="Bogerd H.P."/>
        <person name="Cullen B.R."/>
      </authorList>
      <dbReference type="PubMed" id="15152192"/>
      <dbReference type="DOI" id="10.1038/sj.emboj.7600246"/>
    </citation>
    <scope>FUNCTION IN HIV-1 INFECTIVITY</scope>
    <scope>INTERACTION WITH HIV-1 VIF (MICROBIAL INFECTION)</scope>
    <scope>TISSUE SPECIFICITY</scope>
  </reference>
  <reference key="10">
    <citation type="journal article" date="2006" name="Curr. Biol." volume="16" first="480" last="485">
      <title>APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons.</title>
      <authorList>
        <person name="Chen H."/>
        <person name="Lilley C.E."/>
        <person name="Yu Q."/>
        <person name="Lee D.V."/>
        <person name="Chou J."/>
        <person name="Narvaiza I."/>
        <person name="Landau N.R."/>
        <person name="Weitzman M.D."/>
      </authorList>
      <dbReference type="PubMed" id="16527742"/>
      <dbReference type="DOI" id="10.1016/j.cub.2006.01.031"/>
    </citation>
    <scope>FUNCTION IN RETROTRANSPOSITION</scope>
    <scope>SUBCELLULAR LOCATION</scope>
  </reference>
  <reference key="11">
    <citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="36624" last="36631">
      <title>Reversed functional organization of mouse and human APOBEC3 cytidine deaminase domains.</title>
      <authorList>
        <person name="Hakata Y."/>
        <person name="Landau N.R."/>
      </authorList>
      <dbReference type="PubMed" id="17020885"/>
      <dbReference type="DOI" id="10.1074/jbc.m604980200"/>
    </citation>
    <scope>DOMAIN CMP/DCMP DEAMINASE</scope>
    <scope>MUTAGENESIS OF GLU-67 AND GLU-251</scope>
  </reference>
  <reference key="12">
    <citation type="journal article" date="2006" name="J. Virol." volume="80" first="605" last="614">
      <title>Restriction of foamy viruses by APOBEC cytidine deaminases.</title>
      <authorList>
        <person name="Delebecque F."/>
        <person name="Suspene R."/>
        <person name="Calattini S."/>
        <person name="Casartelli N."/>
        <person name="Saib A."/>
        <person name="Froment A."/>
        <person name="Wain-Hobson S."/>
        <person name="Gessain A."/>
        <person name="Vartanian J.P."/>
        <person name="Schwartz O."/>
      </authorList>
      <dbReference type="PubMed" id="16378963"/>
      <dbReference type="DOI" id="10.1128/jvi.80.2.605-614.2006"/>
    </citation>
    <scope>FUNCTION IN SFV RESTRICTION</scope>
  </reference>
  <reference key="13">
    <citation type="journal article" date="2006" name="PLoS Pathog." volume="2" first="E41" last="E41">
      <title>Human retroviral host restriction factors APOBEC3G and APOBEC3F localize to mRNA processing bodies.</title>
      <authorList>
        <person name="Wichroski M.J."/>
        <person name="Robb G.B."/>
        <person name="Rana T.M."/>
      </authorList>
      <dbReference type="PubMed" id="16699599"/>
      <dbReference type="DOI" id="10.1371/journal.ppat.0020041"/>
    </citation>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>INTERACTION WITH APOBEC3G</scope>
  </reference>
  <reference key="14">
    <citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="2587" last="2595">
      <title>APOBEC3F can inhibit the accumulation of HIV-1 reverse transcription products in the absence of hypermutation. Comparisons with APOBEC3G.</title>
      <authorList>
        <person name="Holmes R.K."/>
        <person name="Koning F.A."/>
        <person name="Bishop K.N."/>
        <person name="Malim M.H."/>
      </authorList>
      <dbReference type="PubMed" id="17121840"/>
      <dbReference type="DOI" id="10.1074/jbc.m607298200"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>CATALYTIC ACTIVITY</scope>
    <scope>MUTAGENESIS OF HIS-65; GLU-67; CYS-96; CYS-99; HIS-249; GLU-251; CYS-280 AND CYS-283</scope>
  </reference>
  <reference key="15">
    <citation type="journal article" date="2008" name="Annu. Rev. Immunol." volume="26" first="317" last="353">
      <title>The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements.</title>
      <authorList>
        <person name="Chiu Y.L."/>
        <person name="Greene W.C."/>
      </authorList>
      <dbReference type="PubMed" id="18304004"/>
      <dbReference type="DOI" id="10.1146/annurev.immunol.26.021607.090350"/>
    </citation>
    <scope>REVIEW</scope>
  </reference>
  <reference key="16">
    <citation type="journal article" date="2008" name="Curr. Opin. Infect. Dis." volume="21" first="298" last="303">
      <title>Hepatitis B: modern concepts in pathogenesis--APOBEC3 cytidine deaminases as effectors in innate immunity against the hepatitis B virus.</title>
      <authorList>
        <person name="Bonvin M."/>
        <person name="Greeve J."/>
      </authorList>
      <dbReference type="PubMed" id="18448976"/>
      <dbReference type="DOI" id="10.1097/qco.0b013e3282fe1bb2"/>
    </citation>
    <scope>REVIEW ON FUNCTION IN HBV RESTRICTION</scope>
  </reference>
  <reference key="17">
    <citation type="journal article" date="2009" name="J. Virol." volume="83" first="7547" last="7559">
      <title>Restriction of equine infectious anemia virus by equine APOBEC3 cytidine deaminases.</title>
      <authorList>
        <person name="Zielonka J."/>
        <person name="Bravo I.G."/>
        <person name="Marino D."/>
        <person name="Conrad E."/>
        <person name="Perkovic M."/>
        <person name="Battenberg M."/>
        <person name="Cichutek K."/>
        <person name="Muenk C."/>
      </authorList>
      <dbReference type="PubMed" id="19458006"/>
      <dbReference type="DOI" id="10.1128/jvi.00015-09"/>
    </citation>
    <scope>FUNCTION IN EIAV RESTRICTION</scope>
  </reference>
  <reference key="18">
    <citation type="journal article" date="2010" name="J. Virol." volume="84" first="5250" last="5259">
      <title>APOBEC3F and APOBEC3G inhibit HIV-1 DNA integration by different mechanisms.</title>
      <authorList>
        <person name="Mbisa J.L."/>
        <person name="Bu W."/>
        <person name="Pathak V.K."/>
      </authorList>
      <dbReference type="PubMed" id="20219927"/>
      <dbReference type="DOI" id="10.1128/jvi.02358-09"/>
    </citation>
    <scope>FUNCTION IN HIV-1 RESTRICTION</scope>
  </reference>
  <reference key="19">
    <citation type="journal article" date="2010" name="J. Virol." volume="84" first="5719" last="5729">
      <title>Inhibition of xenotropic murine leukemia virus-related virus by APOBEC3 proteins and antiviral drugs.</title>
      <authorList>
        <person name="Paprotka T."/>
        <person name="Venkatachari N.J."/>
        <person name="Chaipan C."/>
        <person name="Burdick R."/>
        <person name="Delviks-Frankenberry K.A."/>
        <person name="Hu W.S."/>
        <person name="Pathak V.K."/>
      </authorList>
      <dbReference type="PubMed" id="20335265"/>
      <dbReference type="DOI" id="10.1128/jvi.00134-10"/>
    </citation>
    <scope>FUNCTION IN XMRV RESTRICTION</scope>
  </reference>
  <reference key="20">
    <citation type="journal article" date="2010" name="Nat. Struct. Mol. Biol." volume="17" first="222" last="229">
      <title>APOBEC3 proteins mediate the clearance of foreign DNA from human cells.</title>
      <authorList>
        <person name="Stenglein M.D."/>
        <person name="Burns M.B."/>
        <person name="Li M."/>
        <person name="Lengyel J."/>
        <person name="Harris R.S."/>
      </authorList>
      <dbReference type="PubMed" id="20062055"/>
      <dbReference type="DOI" id="10.1038/nsmb.1744"/>
    </citation>
    <scope>FUNCTION IN RETROTRANSPOSITION</scope>
  </reference>
  <reference key="21">
    <citation type="journal article" date="2010" name="Nucleic Acids Res." volume="38" first="4274" last="4284">
      <title>Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction.</title>
      <authorList>
        <person name="Refsland E.W."/>
        <person name="Stenglein M.D."/>
        <person name="Shindo K."/>
        <person name="Albin J.S."/>
        <person name="Brown W.L."/>
        <person name="Harris R.S."/>
      </authorList>
      <dbReference type="PubMed" id="20308164"/>
      <dbReference type="DOI" id="10.1093/nar/gkq174"/>
    </citation>
    <scope>TISSUE SPECIFICITY</scope>
  </reference>
  <reference key="22">
    <citation type="journal article" date="2011" name="Cell" volume="145" first="423" last="434">
      <title>Hydroxylation of 5-methylcytosine by TET1 promotes active DNA demethylation in the adult brain.</title>
      <authorList>
        <person name="Guo J.U."/>
        <person name="Su Y."/>
        <person name="Zhong C."/>
        <person name="Ming G.L."/>
        <person name="Song H."/>
      </authorList>
      <dbReference type="PubMed" id="21496894"/>
      <dbReference type="DOI" id="10.1016/j.cell.2011.03.022"/>
    </citation>
    <scope>FUNCTION IN DNA DEMETHYLATION</scope>
  </reference>
  <reference key="23">
    <citation type="journal article" date="2011" name="J. Virol." volume="85" first="11220" last="11234">
      <title>Human and rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H demonstrate a conserved capacity to restrict Vif-deficient HIV-1.</title>
      <authorList>
        <person name="Hultquist J.F."/>
        <person name="Lengyel J.A."/>
        <person name="Refsland E.W."/>
        <person name="LaRue R.S."/>
        <person name="Lackey L."/>
        <person name="Brown W.L."/>
        <person name="Harris R.S."/>
      </authorList>
      <dbReference type="PubMed" id="21835787"/>
      <dbReference type="DOI" id="10.1128/jvi.05238-11"/>
    </citation>
    <scope>FUNCTION IN HIV-1 RESTRICTION</scope>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>ACTIVITY REGULATION (MICROBIAL INFECTION)</scope>
    <scope>UBIQUITINATION (MICROBIAL INFECTION)</scope>
    <scope>INTERACTION WITH HIV-1 VIF (MICROBIAL INFECTION)</scope>
  </reference>
  <reference key="24">
    <citation type="journal article" date="2011" name="Nature" volume="481" first="371" last="375">
      <title>Vif hijacks CBF-beta to degrade APOBEC3G and promote HIV-1 infection.</title>
      <authorList>
        <person name="Jaeger S."/>
        <person name="Kim D.Y."/>
        <person name="Hultquist J.F."/>
        <person name="Shindo K."/>
        <person name="LaRue R.S."/>
        <person name="Kwon E."/>
        <person name="Li M."/>
        <person name="Anderson B.D."/>
        <person name="Yen L."/>
        <person name="Stanley D."/>
        <person name="Mahon C."/>
        <person name="Kane J."/>
        <person name="Franks-Skiba K."/>
        <person name="Cimermancic P."/>
        <person name="Burlingame A."/>
        <person name="Sali A."/>
        <person name="Craik C.S."/>
        <person name="Harris R.S."/>
        <person name="Gross J.D."/>
        <person name="Krogan N.J."/>
      </authorList>
      <dbReference type="PubMed" id="22190037"/>
      <dbReference type="DOI" id="10.1038/nature10693"/>
    </citation>
    <scope>ACTIVITY REGULATION (MICROBIAL INFECTION)</scope>
    <scope>UBIQUITINATION (MICROBIAL INFECTION)</scope>
    <scope>INTERACTION WITH HIV-1 VIF (MICROBIAL INFECTION)</scope>
  </reference>
  <reference key="25">
    <citation type="journal article" date="2012" name="Front. Microbiol." volume="3" first="275" last="275">
      <title>Retroelements versus APOBEC3 family members: No great escape from the magnificent seven.</title>
      <authorList>
        <person name="Arias J.F."/>
        <person name="Koyama T."/>
        <person name="Kinomoto M."/>
        <person name="Tokunaga K."/>
      </authorList>
      <dbReference type="PubMed" id="22912627"/>
      <dbReference type="DOI" id="10.3389/fmicb.2012.00275"/>
    </citation>
    <scope>REVIEW</scope>
  </reference>
  <reference key="26">
    <citation type="journal article" date="2012" name="J. Virol." volume="86" first="11712" last="11724">
      <title>HIV-1 replication and APOBEC3 antiviral activity are not regulated by P bodies.</title>
      <authorList>
        <person name="Phalora P.K."/>
        <person name="Sherer N.M."/>
        <person name="Wolinsky S.M."/>
        <person name="Swanson C.M."/>
        <person name="Malim M.H."/>
      </authorList>
      <dbReference type="PubMed" id="22915799"/>
      <dbReference type="DOI" id="10.1128/jvi.00595-12"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>INTERACTION WITH AGO1; AGO2 AND AGO3</scope>
  </reference>
  <reference key="27">
    <citation type="journal article" date="2012" name="Nat. Struct. Mol. Biol." volume="19" first="1005" last="1010">
      <title>The APOBEC3C crystal structure and the interface for HIV-1 Vif binding.</title>
      <authorList>
        <person name="Kitamura S."/>
        <person name="Ode H."/>
        <person name="Nakashima M."/>
        <person name="Imahashi M."/>
        <person name="Naganawa Y."/>
        <person name="Kurosawa T."/>
        <person name="Yokomaku Y."/>
        <person name="Yamane T."/>
        <person name="Watanabe N."/>
        <person name="Suzuki A."/>
        <person name="Sugiura W."/>
        <person name="Iwatani Y."/>
      </authorList>
      <dbReference type="PubMed" id="23001005"/>
      <dbReference type="DOI" id="10.1038/nsmb.2378"/>
    </citation>
    <scope>FUNCTION IN HIV-1 INFECTIVITY</scope>
    <scope>INTERACTION WITH HIV-1 VIF (MICROBIAL INFECTION)</scope>
    <scope>MUTAGENESIS OF GLU-251; LEU-255; PHE-258; CYS-259; 262-ILE-LEU-263; SER-264; TYR-269; GLU-289; PHE-290; HIS-294 AND GLU-324</scope>
  </reference>
  <reference key="28">
    <citation type="journal article" date="2012" name="PLoS Pathog." volume="8" first="E1002800" last="E1002800">
      <title>Endogenous origins of HIV-1 G-to-A hypermutation and restriction in the nonpermissive T cell line CEM2n.</title>
      <authorList>
        <person name="Refsland E.W."/>
        <person name="Hultquist J.F."/>
        <person name="Harris R.S."/>
      </authorList>
      <dbReference type="PubMed" id="22807680"/>
      <dbReference type="DOI" id="10.1371/journal.ppat.1002800"/>
    </citation>
    <scope>FUNCTION IN HIV-1 RESTRICTION</scope>
  </reference>
  <reference key="29">
    <citation type="journal article" date="2012" name="Semin. Cell Dev. Biol." volume="23" first="258" last="268">
      <title>Functions and regulation of the APOBEC family of proteins.</title>
      <authorList>
        <person name="Smith H.C."/>
        <person name="Bennett R.P."/>
        <person name="Kizilyer A."/>
        <person name="McDougall W.M."/>
        <person name="Prohaska K.M."/>
      </authorList>
      <dbReference type="PubMed" id="22001110"/>
      <dbReference type="DOI" id="10.1016/j.semcdb.2011.10.004"/>
    </citation>
    <scope>REVIEW</scope>
  </reference>
  <reference key="30">
    <citation type="journal article" date="2013" name="J. Mol. Biol." volume="425" first="1172" last="1182">
      <title>Dispersed sites of HIV Vif-dependent polyubiquitination in the DNA deaminase APOBEC3F.</title>
      <authorList>
        <person name="Albin J.S."/>
        <person name="Anderson J.S."/>
        <person name="Johnson J.R."/>
        <person name="Harjes E."/>
        <person name="Matsuo H."/>
        <person name="Krogan N.J."/>
        <person name="Harris R.S."/>
      </authorList>
      <dbReference type="PubMed" id="23318957"/>
      <dbReference type="DOI" id="10.1016/j.jmb.2013.01.010"/>
    </citation>
    <scope>UBIQUITINATION AT LYS-52; LYS-234; LYS-334; LYS-352; LYS-355 AND LYS-358 (MICROBIAL INFECTION)</scope>
  </reference>
  <reference key="31">
    <citation type="journal article" date="2013" name="J. Virol." volume="87" first="444" last="453">
      <title>APOBEC3G restricts HIV-1 to a greater extent than APOBEC3F and APOBEC3DE in human primary CD4+ t cells and macrophages.</title>
      <authorList>
        <person name="Chaipan C."/>
        <person name="Smith J.L."/>
        <person name="Hu W.S."/>
        <person name="Pathak V.K."/>
      </authorList>
      <dbReference type="PubMed" id="23097438"/>
      <dbReference type="DOI" id="10.1128/jvi.00676-12"/>
    </citation>
    <scope>FUNCTION IN HIV-1 RESTRICTION</scope>
  </reference>
  <reference key="32">
    <citation type="journal article" date="2013" name="J. Virol." volume="87" first="1508" last="1517">
      <title>The suppression of HIV-1 infection by APOBEC3 proteins in primary human CD4+ T cells is associated with the inhibition of processive reverse transcription as well as excessive cytidine deamination.</title>
      <authorList>
        <person name="Gillick K."/>
        <person name="Pollpeter D."/>
        <person name="Phalora P."/>
        <person name="Kim E.Y."/>
        <person name="Wolinsky S.M."/>
        <person name="Malim M.H."/>
      </authorList>
      <dbReference type="PubMed" id="23152537"/>
      <dbReference type="DOI" id="10.1128/jvi.02587-12"/>
    </citation>
    <scope>FUNCTION IN HIV-1 RESTRICTION</scope>
  </reference>
  <reference key="33">
    <citation type="journal article" date="2022" name="J. Mol. Biol." volume="434" first="167355" last="167355">
      <title>Differential Activity of APOBEC3F, APOBEC3G, and APOBEC3H in the Restriction of HIV-2.</title>
      <authorList>
        <person name="Meissner M.E."/>
        <person name="Willkomm N.A."/>
        <person name="Lucas J."/>
        <person name="Arndt W.G."/>
        <person name="Aitken S.F."/>
        <person name="Julik E.J."/>
        <person name="Baliga S."/>
        <person name="Mansky L.M."/>
      </authorList>
      <dbReference type="PubMed" id="34774569"/>
      <dbReference type="DOI" id="10.1016/j.jmb.2021.167355"/>
    </citation>
    <scope>FUNCTION</scope>
  </reference>
  <reference evidence="35 36" key="34">
    <citation type="journal article" date="2016" name="J. Mol. Biol." volume="428" first="2307" last="2316">
      <title>1.92 Angstrom Zinc-Free APOBEC3F Catalytic Domain Crystal Structure.</title>
      <authorList>
        <person name="Shaban N.M."/>
        <person name="Shi K."/>
        <person name="Li M."/>
        <person name="Aihara H."/>
        <person name="Harris R.S."/>
      </authorList>
      <dbReference type="PubMed" id="27139641"/>
      <dbReference type="DOI" id="10.1016/j.jmb.2016.04.026"/>
    </citation>
    <scope>X-RAY CRYSTALLOGRAPHY (1.92 ANGSTROMS) OF 185-373 IN COMPLEX WITH ZINC</scope>
    <scope>SUBUNIT</scope>
    <scope>COFACTOR</scope>
    <scope>DISULFIDE BOND</scope>
  </reference>
  <reference evidence="37" key="35">
    <citation type="journal article" date="2019" name="Nat. Struct. Mol. Biol." volume="26" first="1176" last="1183">
      <title>Structural basis of antagonism of human APOBEC3F by HIV-1 Vif.</title>
      <authorList>
        <person name="Hu Y."/>
        <person name="Desimmie B.A."/>
        <person name="Nguyen H.C."/>
        <person name="Ziegler S.J."/>
        <person name="Cheng T.C."/>
        <person name="Chen J."/>
        <person name="Wang J."/>
        <person name="Wang H."/>
        <person name="Zhang K."/>
        <person name="Pathak V.K."/>
        <person name="Xiong Y."/>
      </authorList>
      <dbReference type="PubMed" id="31792451"/>
      <dbReference type="DOI" id="10.1038/s41594-019-0343-6"/>
    </citation>
    <scope>STRUCTURE BY ELECTRON MICROSCOPY (3.90 ANGSTROMS) OF 185-373 IN COMPLEX WITH CBFB; HIV-1 VIF AND ZINC</scope>
    <scope>SUBUNIT</scope>
    <scope>COFACTOR</scope>
    <scope>ACTIVE SITE</scope>
    <scope>ACTIVITY REGULATION (MICROBIAL INFECTION)</scope>
    <scope>UBIQUITINATION (MICROBIAL INFECTION)</scope>
    <scope>INTERACTION WITH HIV-1 VIF (MICROBIAL INFECTION)</scope>
    <scope>INTERACTION WITH APOBEC3G</scope>
    <scope>MUTAGENESIS OF 260-ASP-ASP-261; PRO-265; GLU-289; ARG-293; GLU-324 AND ASP-347</scope>
  </reference>
  <comment type="function">
    <text evidence="3 4 6 7 11 12 13 15 16 17 19 20 21 22 23 26">DNA deaminase (cytidine deaminase) which acts as an inhibitor of retrovirus replication and retrotransposon mobility via deaminase-dependent and -independent mechanisms (PubMed:15141007, PubMed:20062055, PubMed:22915799, PubMed:34774569). Exhibits antiviral activity against viruse such as HIV-1 or HIV-2 (PubMed:15141007, PubMed:15152192, PubMed:20219927, PubMed:21835787, PubMed:22807680, PubMed:23001005, PubMed:23097438, PubMed:23152537, PubMed:34774569). After the penetration of retroviral nucleocapsids into target cells of infection and the initiation of reverse transcription, it can induce the conversion of cytosine to uracil in the minus-sense single-strand viral DNA, leading to G-to-A hypermutations in the subsequent plus-strand viral DNA (PubMed:15141007). The resultant detrimental levels of mutations in the proviral genome, along with a deamination-independent mechanism that works prior to the proviral integration, together exert efficient antiretroviral effects in infected target cells (PubMed:15141007). Selectively targets single-stranded DNA and does not deaminate double-stranded DNA or single- or double-stranded RNA (PubMed:15141007). Exhibits antiviral activity also against hepatitis B virus (HBV), equine infectious anemia virus (EIAV), xenotropic MuLV-related virus (XMRV) and simian foamy virus (SFV) and may inhibit the mobility of LTR and non-LTR retrotransposons (PubMed:16378963, PubMed:16527742, PubMed:19458006, PubMed:20062055, PubMed:20335265). May also play a role in the epigenetic regulation of gene expression through the process of active DNA demethylation (PubMed:21496894).</text>
  </comment>
  <comment type="catalytic activity">
    <reaction>
      <text>a 2'-deoxycytidine in single-stranded DNA + H(+) + H2O = a 2'-deoxyuridine in single-stranded DNA + NH4(+)</text>
      <dbReference type="Rhea" id="RHEA:50948"/>
      <dbReference type="Rhea" id="RHEA-COMP:12846"/>
      <dbReference type="Rhea" id="RHEA-COMP:12847"/>
      <dbReference type="ChEBI" id="CHEBI:15377"/>
      <dbReference type="ChEBI" id="CHEBI:15378"/>
      <dbReference type="ChEBI" id="CHEBI:28938"/>
      <dbReference type="ChEBI" id="CHEBI:85452"/>
      <dbReference type="ChEBI" id="CHEBI:133902"/>
      <dbReference type="EC" id="3.5.4.38"/>
    </reaction>
  </comment>
  <comment type="cofactor">
    <cofactor evidence="24 25">
      <name>Zn(2+)</name>
      <dbReference type="ChEBI" id="CHEBI:29105"/>
    </cofactor>
  </comment>
  <comment type="activity regulation">
    <text evidence="17 18 25">(Microbial infection) Antiviral activity is neutralized by the HIV-1 virion infectivity factor (Vif), that prevents its incorporation into progeny virions by both inhibiting its translation and/or by inducing its ubiquitination and subsequent degradation by the 26S proteasome.</text>
  </comment>
  <comment type="subunit">
    <text evidence="8 20 24 25">Homodimer (PubMed:27139641). Interacts with APOBEC3G in an RNA-dependent manner (PubMed:16699599, PubMed:31792451). Interacts with AGO1, AGO2 and AGO3 (PubMed:22915799).</text>
  </comment>
  <comment type="subunit">
    <text evidence="4 17 18 21 25">(Microbial infection) Interacts with HIV-1 Vif, leading to its ubiquitination and degradation by the proteasome (PubMed:15152192, PubMed:22190037, PubMed:23001005, PubMed:31792451). In the absence of Vif protein, specifically packaged into HIV-1 virions (PubMed:15152192).</text>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-11306991">
      <id>Q8IUX4</id>
    </interactant>
    <interactant intactId="EBI-11306991">
      <id>Q8IUX4</id>
      <label>APOBEC3F</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>2</experiments>
  </comment>
  <comment type="subcellular location">
    <subcellularLocation>
      <location evidence="7 8 17">Cytoplasm</location>
    </subcellularLocation>
    <subcellularLocation>
      <location evidence="8 20">Cytoplasm</location>
      <location evidence="8 20">P-body</location>
    </subcellularLocation>
  </comment>
  <comment type="alternative products">
    <event type="alternative splicing"/>
    <isoform>
      <id>Q8IUX4-1</id>
      <name>1</name>
      <sequence type="displayed"/>
    </isoform>
    <isoform>
      <id>Q8IUX4-2</id>
      <name>2</name>
      <sequence type="described" ref="VSP_009803 VSP_009804"/>
    </isoform>
    <isoform>
      <id>Q8IUX4-3</id>
      <name>3</name>
      <sequence type="described" ref="VSP_042754 VSP_042755"/>
    </isoform>
  </comment>
  <comment type="tissue specificity">
    <text evidence="2 4 14">Widely expressed. Highly expressed in ovary.</text>
  </comment>
  <comment type="domain">
    <text evidence="9">The CMP/dCMP deaminase domain 1 mediates RNA binding, RNA-dependent oligomerization and virion incorporation whereas the CMP/dCMP deaminase domain 2 confers deoxycytidine deaminase activity and substrate sequence specificity.</text>
  </comment>
  <comment type="PTM">
    <text evidence="18 25">(Microbial infection) Following infection by HIV-1, ubiquitinated by a cullin-5-RING E3 ubiquitin-protein ligase complex (ECS complex) hijacked by the HIV-1 Vif protein, leading to its degradation.</text>
  </comment>
  <comment type="miscellaneous">
    <text evidence="2">It is one of seven related genes or pseudogenes found in a cluster, thought to result from gene duplication, on chromosome 22.</text>
  </comment>
  <comment type="miscellaneous">
    <molecule>Isoform 2</molecule>
    <text evidence="32">May be due to a competing donor splice site.</text>
  </comment>
  <comment type="similarity">
    <text evidence="32">Belongs to the cytidine and deoxycytidylate deaminase family.</text>
  </comment>
  <dbReference type="EC" id="3.5.4.38" evidence="10"/>
  <dbReference type="EMBL" id="CR456395">
    <property type="protein sequence ID" value="CAG30281.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="DQ146365">
    <property type="protein sequence ID" value="AAZ38720.1"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="AL022318">
    <property type="status" value="NOT_ANNOTATED_CDS"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="CH471095">
    <property type="protein sequence ID" value="EAW60288.1"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="CH471095">
    <property type="protein sequence ID" value="EAW60289.1"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="BC038808">
    <property type="protein sequence ID" value="AAH38808.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="BC061914">
    <property type="protein sequence ID" value="AAH61914.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="CCDS" id="CCDS33648.1">
    <molecule id="Q8IUX4-1"/>
  </dbReference>
  <dbReference type="CCDS" id="CCDS33649.1">
    <molecule id="Q8IUX4-3"/>
  </dbReference>
  <dbReference type="RefSeq" id="NP_001006667.1">
    <molecule id="Q8IUX4-3"/>
    <property type="nucleotide sequence ID" value="NM_001006666.1"/>
  </dbReference>
  <dbReference type="RefSeq" id="NP_660341.2">
    <molecule id="Q8IUX4-1"/>
    <property type="nucleotide sequence ID" value="NM_145298.5"/>
  </dbReference>
  <dbReference type="RefSeq" id="XP_016884132.1">
    <property type="nucleotide sequence ID" value="XM_017028643.1"/>
  </dbReference>
  <dbReference type="PDB" id="3WUS">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.54 A"/>
    <property type="chains" value="A/B=187-373"/>
  </dbReference>
  <dbReference type="PDB" id="4IOU">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.75 A"/>
    <property type="chains" value="A/B/C/D=185-373"/>
  </dbReference>
  <dbReference type="PDB" id="4J4J">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="3.10 A"/>
    <property type="chains" value="A/B=218-373"/>
  </dbReference>
  <dbReference type="PDB" id="5HX4">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="1.92 A"/>
    <property type="chains" value="A/B=185-373"/>
  </dbReference>
  <dbReference type="PDB" id="5HX5">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.33 A"/>
    <property type="chains" value="A/B=185-373"/>
  </dbReference>
  <dbReference type="PDB" id="5W2M">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="3.70 A"/>
    <property type="chains" value="A/B/C/D/J/K/L/M=190-373"/>
  </dbReference>
  <dbReference type="PDB" id="5ZVA">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.30 A"/>
    <property type="chains" value="A/B=220-373"/>
  </dbReference>
  <dbReference type="PDB" id="5ZVB">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.00 A"/>
    <property type="chains" value="A/B=220-373"/>
  </dbReference>
  <dbReference type="PDB" id="6NIL">
    <property type="method" value="EM"/>
    <property type="resolution" value="3.90 A"/>
    <property type="chains" value="A/D/G/J=185-373"/>
  </dbReference>
  <dbReference type="PDBsum" id="3WUS"/>
  <dbReference type="PDBsum" id="4IOU"/>
  <dbReference type="PDBsum" id="4J4J"/>
  <dbReference type="PDBsum" id="5HX4"/>
  <dbReference type="PDBsum" id="5HX5"/>
  <dbReference type="PDBsum" id="5W2M"/>
  <dbReference type="PDBsum" id="5ZVA"/>
  <dbReference type="PDBsum" id="5ZVB"/>
  <dbReference type="PDBsum" id="6NIL"/>
  <dbReference type="AlphaFoldDB" id="Q8IUX4"/>
  <dbReference type="EMDB" id="EMD-9380"/>
  <dbReference type="EMDB" id="EMD-9381"/>
  <dbReference type="SMR" id="Q8IUX4"/>
  <dbReference type="BioGRID" id="128319">
    <property type="interactions" value="151"/>
  </dbReference>
  <dbReference type="DIP" id="DIP-59966N"/>
  <dbReference type="IntAct" id="Q8IUX4">
    <property type="interactions" value="61"/>
  </dbReference>
  <dbReference type="STRING" id="9606.ENSP00000309749"/>
  <dbReference type="ChEMBL" id="CHEMBL2007626"/>
  <dbReference type="iPTMnet" id="Q8IUX4"/>
  <dbReference type="PhosphoSitePlus" id="Q8IUX4"/>
  <dbReference type="BioMuta" id="APOBEC3F"/>
  <dbReference type="DMDM" id="161784334"/>
  <dbReference type="jPOST" id="Q8IUX4"/>
  <dbReference type="MassIVE" id="Q8IUX4"/>
  <dbReference type="PaxDb" id="9606-ENSP00000309749"/>
  <dbReference type="PeptideAtlas" id="Q8IUX4"/>
  <dbReference type="ProteomicsDB" id="70623">
    <molecule id="Q8IUX4-1"/>
  </dbReference>
  <dbReference type="ProteomicsDB" id="70624">
    <molecule id="Q8IUX4-2"/>
  </dbReference>
  <dbReference type="ProteomicsDB" id="70625">
    <molecule id="Q8IUX4-3"/>
  </dbReference>
  <dbReference type="Pumba" id="Q8IUX4"/>
  <dbReference type="Antibodypedia" id="34783">
    <property type="antibodies" value="231 antibodies from 21 providers"/>
  </dbReference>
  <dbReference type="DNASU" id="200316"/>
  <dbReference type="Ensembl" id="ENST00000308521.10">
    <molecule id="Q8IUX4-1"/>
    <property type="protein sequence ID" value="ENSP00000309749.5"/>
    <property type="gene ID" value="ENSG00000128394.17"/>
  </dbReference>
  <dbReference type="Ensembl" id="ENST00000381565.2">
    <molecule id="Q8IUX4-3"/>
    <property type="protein sequence ID" value="ENSP00000370977.2"/>
    <property type="gene ID" value="ENSG00000128394.17"/>
  </dbReference>
  <dbReference type="GeneID" id="200316"/>
  <dbReference type="KEGG" id="hsa:200316"/>
  <dbReference type="MANE-Select" id="ENST00000308521.10">
    <property type="protein sequence ID" value="ENSP00000309749.5"/>
    <property type="RefSeq nucleotide sequence ID" value="NM_145298.6"/>
    <property type="RefSeq protein sequence ID" value="NP_660341.2"/>
  </dbReference>
  <dbReference type="UCSC" id="uc003awv.4">
    <molecule id="Q8IUX4-1"/>
    <property type="organism name" value="human"/>
  </dbReference>
  <dbReference type="AGR" id="HGNC:17356"/>
  <dbReference type="CTD" id="200316"/>
  <dbReference type="DisGeNET" id="200316"/>
  <dbReference type="GeneCards" id="APOBEC3F"/>
  <dbReference type="HGNC" id="HGNC:17356">
    <property type="gene designation" value="APOBEC3F"/>
  </dbReference>
  <dbReference type="HPA" id="ENSG00000128394">
    <property type="expression patterns" value="Low tissue specificity"/>
  </dbReference>
  <dbReference type="MIM" id="608993">
    <property type="type" value="gene"/>
  </dbReference>
  <dbReference type="neXtProt" id="NX_Q8IUX4"/>
  <dbReference type="OpenTargets" id="ENSG00000128394"/>
  <dbReference type="PharmGKB" id="PA24896"/>
  <dbReference type="VEuPathDB" id="HostDB:ENSG00000128394"/>
  <dbReference type="eggNOG" id="KOG4075">
    <property type="taxonomic scope" value="Eukaryota"/>
  </dbReference>
  <dbReference type="GeneTree" id="ENSGT00940000162695"/>
  <dbReference type="HOGENOM" id="CLU_047918_0_0_1"/>
  <dbReference type="InParanoid" id="Q8IUX4"/>
  <dbReference type="OMA" id="RNPMEAT"/>
  <dbReference type="OrthoDB" id="5355962at2759"/>
  <dbReference type="PhylomeDB" id="Q8IUX4"/>
  <dbReference type="TreeFam" id="TF331356"/>
  <dbReference type="BRENDA" id="3.5.4.38">
    <property type="organism ID" value="2681"/>
  </dbReference>
  <dbReference type="PathwayCommons" id="Q8IUX4"/>
  <dbReference type="SignaLink" id="Q8IUX4"/>
  <dbReference type="SIGNOR" id="Q8IUX4"/>
  <dbReference type="BioGRID-ORCS" id="200316">
    <property type="hits" value="17 hits in 1105 CRISPR screens"/>
  </dbReference>
  <dbReference type="ChiTaRS" id="APOBEC3F">
    <property type="organism name" value="human"/>
  </dbReference>
  <dbReference type="EvolutionaryTrace" id="Q8IUX4"/>
  <dbReference type="GeneWiki" id="APOBEC3F"/>
  <dbReference type="GenomeRNAi" id="200316"/>
  <dbReference type="Pharos" id="Q8IUX4">
    <property type="development level" value="Tbio"/>
  </dbReference>
  <dbReference type="PRO" id="PR:Q8IUX4"/>
  <dbReference type="Proteomes" id="UP000005640">
    <property type="component" value="Chromosome 22"/>
  </dbReference>
  <dbReference type="RNAct" id="Q8IUX4">
    <property type="molecule type" value="protein"/>
  </dbReference>
  <dbReference type="Bgee" id="ENSG00000128394">
    <property type="expression patterns" value="Expressed in granulocyte and 104 other cell types or tissues"/>
  </dbReference>
  <dbReference type="GO" id="GO:0030895">
    <property type="term" value="C:apolipoprotein B mRNA editing enzyme complex"/>
    <property type="evidence" value="ECO:0000304"/>
    <property type="project" value="HGNC-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005737">
    <property type="term" value="C:cytoplasm"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005634">
    <property type="term" value="C:nucleus"/>
    <property type="evidence" value="ECO:0000318"/>
    <property type="project" value="GO_Central"/>
  </dbReference>
  <dbReference type="GO" id="GO:0000932">
    <property type="term" value="C:P-body"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:1990904">
    <property type="term" value="C:ribonucleoprotein complex"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0004126">
    <property type="term" value="F:cytidine deaminase activity"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="HGNC-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0042802">
    <property type="term" value="F:identical protein binding"/>
    <property type="evidence" value="ECO:0000353"/>
    <property type="project" value="IntAct"/>
  </dbReference>
  <dbReference type="GO" id="GO:0003723">
    <property type="term" value="F:RNA binding"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="HGNC-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0008270">
    <property type="term" value="F:zinc ion binding"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="HGNC-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0016553">
    <property type="term" value="P:base conversion or substitution editing"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="HGNC-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0044355">
    <property type="term" value="P:clearance of foreign intracellular DNA"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="GO_Central"/>
  </dbReference>
  <dbReference type="GO" id="GO:0016554">
    <property type="term" value="P:cytidine to uridine editing"/>
    <property type="evidence" value="ECO:0000318"/>
    <property type="project" value="GO_Central"/>
  </dbReference>
  <dbReference type="GO" id="GO:0051607">
    <property type="term" value="P:defense response to virus"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0070383">
    <property type="term" value="P:DNA cytosine deamination"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0045087">
    <property type="term" value="P:innate immune response"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="HGNC-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0045869">
    <property type="term" value="P:negative regulation of single stranded viral RNA replication via double stranded DNA intermediate"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0045071">
    <property type="term" value="P:negative regulation of viral genome replication"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0048525">
    <property type="term" value="P:negative regulation of viral process"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="HGNC-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0002230">
    <property type="term" value="P:positive regulation of defense response to virus by host"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="HGNC-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0044029">
    <property type="term" value="P:positive regulation of gene expression via chromosomal CpG island demethylation"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0010526">
    <property type="term" value="P:retrotransposon silencing"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="CDD" id="cd01283">
    <property type="entry name" value="cytidine_deaminase"/>
    <property type="match status" value="2"/>
  </dbReference>
  <dbReference type="Gene3D" id="3.40.140.10">
    <property type="entry name" value="Cytidine Deaminase, domain 2"/>
    <property type="match status" value="2"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR016192">
    <property type="entry name" value="APOBEC/CMP_deaminase_Zn-bd"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR050610">
    <property type="entry name" value="APOBEC_Cyt_Deaminase"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR002125">
    <property type="entry name" value="CMP_dCMP_dom"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR016193">
    <property type="entry name" value="Cytidine_deaminase-like"/>
  </dbReference>
  <dbReference type="PANTHER" id="PTHR13857:SF45">
    <property type="entry name" value="DNA DC-DU-EDITING ENZYME APOBEC-3F"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="PANTHER" id="PTHR13857">
    <property type="entry name" value="MRNA EDITING ENZYME"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Pfam" id="PF18782">
    <property type="entry name" value="NAD2"/>
    <property type="match status" value="2"/>
  </dbReference>
  <dbReference type="SUPFAM" id="SSF53927">
    <property type="entry name" value="Cytidine deaminase-like"/>
    <property type="match status" value="2"/>
  </dbReference>
  <dbReference type="PROSITE" id="PS00903">
    <property type="entry name" value="CYT_DCMP_DEAMINASES_1"/>
    <property type="match status" value="2"/>
  </dbReference>
  <dbReference type="PROSITE" id="PS51747">
    <property type="entry name" value="CYT_DCMP_DEAMINASES_2"/>
    <property type="match status" value="2"/>
  </dbReference>
  <proteinExistence type="evidence at protein level"/>
  <keyword id="KW-0002">3D-structure</keyword>
  <keyword id="KW-0025">Alternative splicing</keyword>
  <keyword id="KW-0051">Antiviral defense</keyword>
  <keyword id="KW-0963">Cytoplasm</keyword>
  <keyword id="KW-1015">Disulfide bond</keyword>
  <keyword id="KW-0945">Host-virus interaction</keyword>
  <keyword id="KW-0378">Hydrolase</keyword>
  <keyword id="KW-0391">Immunity</keyword>
  <keyword id="KW-0399">Innate immunity</keyword>
  <keyword id="KW-1017">Isopeptide bond</keyword>
  <keyword id="KW-0479">Metal-binding</keyword>
  <keyword id="KW-1267">Proteomics identification</keyword>
  <keyword id="KW-1185">Reference proteome</keyword>
  <keyword id="KW-0677">Repeat</keyword>
  <keyword id="KW-0832">Ubl conjugation</keyword>
  <keyword id="KW-0862">Zinc</keyword>
  <feature type="chain" id="PRO_0000171757" description="DNA dC-&gt;dU-editing enzyme APOBEC-3F">
    <location>
      <begin position="1"/>
      <end position="373"/>
    </location>
  </feature>
  <feature type="domain" description="CMP/dCMP-type deaminase 1" evidence="1">
    <location>
      <begin position="29"/>
      <end position="137"/>
    </location>
  </feature>
  <feature type="domain" description="CMP/dCMP-type deaminase 2" evidence="1">
    <location>
      <begin position="174"/>
      <end position="321"/>
    </location>
  </feature>
  <feature type="active site" description="Proton donor" evidence="1 25 37">
    <location>
      <position position="251"/>
    </location>
  </feature>
  <feature type="binding site" evidence="1">
    <location>
      <position position="65"/>
    </location>
    <ligand>
      <name>Zn(2+)</name>
      <dbReference type="ChEBI" id="CHEBI:29105"/>
      <label>1</label>
    </ligand>
  </feature>
  <feature type="binding site" evidence="1">
    <location>
      <position position="96"/>
    </location>
    <ligand>
      <name>Zn(2+)</name>
      <dbReference type="ChEBI" id="CHEBI:29105"/>
      <label>1</label>
    </ligand>
  </feature>
  <feature type="binding site" evidence="1">
    <location>
      <position position="99"/>
    </location>
    <ligand>
      <name>Zn(2+)</name>
      <dbReference type="ChEBI" id="CHEBI:29105"/>
      <label>1</label>
    </ligand>
  </feature>
  <feature type="binding site" evidence="1 24 25 37">
    <location>
      <position position="249"/>
    </location>
    <ligand>
      <name>Zn(2+)</name>
      <dbReference type="ChEBI" id="CHEBI:29105"/>
      <label>2</label>
      <note>catalytic</note>
    </ligand>
  </feature>
  <feature type="binding site" evidence="1 24 25 37">
    <location>
      <position position="280"/>
    </location>
    <ligand>
      <name>Zn(2+)</name>
      <dbReference type="ChEBI" id="CHEBI:29105"/>
      <label>2</label>
      <note>catalytic</note>
    </ligand>
  </feature>
  <feature type="binding site" evidence="1 24 25 37">
    <location>
      <position position="283"/>
    </location>
    <ligand>
      <name>Zn(2+)</name>
      <dbReference type="ChEBI" id="CHEBI:29105"/>
      <label>2</label>
      <note>catalytic</note>
    </ligand>
  </feature>
  <feature type="disulfide bond" evidence="24 35">
    <location>
      <begin position="280"/>
      <end position="283"/>
    </location>
  </feature>
  <feature type="cross-link" description="(Microbial infection) Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="33">
    <location>
      <position position="52"/>
    </location>
  </feature>
  <feature type="cross-link" description="(Microbial infection) Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="33">
    <location>
      <position position="234"/>
    </location>
  </feature>
  <feature type="cross-link" description="(Microbial infection) Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="33">
    <location>
      <position position="334"/>
    </location>
  </feature>
  <feature type="cross-link" description="(Microbial infection) Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="33">
    <location>
      <position position="352"/>
    </location>
  </feature>
  <feature type="cross-link" description="(Microbial infection) Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="33">
    <location>
      <position position="355"/>
    </location>
  </feature>
  <feature type="cross-link" description="(Microbial infection) Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="33">
    <location>
      <position position="358"/>
    </location>
  </feature>
  <feature type="splice variant" id="VSP_009803" description="In isoform 2." evidence="30">
    <original>VYSQPEHHAEMCFLSWFCGNQL</original>
    <variation>VPPGLQSLCRQELSQLGKQTTH</variation>
    <location>
      <begin position="58"/>
      <end position="79"/>
    </location>
  </feature>
  <feature type="splice variant" id="VSP_042754" description="In isoform 3." evidence="29">
    <original>YSQPEHHAEMCFLSWFCGNQLPAYKCFQITWFVSWTPCPDCVAKLAEFLAEHPNV</original>
    <variation>PRSFIRAPFQVLSSPFGQCAPPHGTAQVQWPPQLTAGREQGRP</variation>
    <location>
      <begin position="59"/>
      <end position="113"/>
    </location>
  </feature>
  <feature type="splice variant" id="VSP_009804" description="In isoform 2." evidence="30">
    <location>
      <begin position="80"/>
      <end position="373"/>
    </location>
  </feature>
  <feature type="splice variant" id="VSP_042755" description="In isoform 3." evidence="29">
    <location>
      <begin position="114"/>
      <end position="373"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_038355" description="In dbSNP:rs35053197." evidence="5">
    <original>R</original>
    <variation>P</variation>
    <location>
      <position position="48"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_018145" description="In dbSNP:rs2076109.">
    <original>Q</original>
    <variation>L</variation>
    <location>
      <position position="61"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_018146" description="In dbSNP:rs201939303.">
    <original>P</original>
    <variation>L</variation>
    <location>
      <position position="97"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_018147" description="In dbSNP:rs2020390." evidence="5">
    <original>A</original>
    <variation>S</variation>
    <location>
      <position position="108"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_025058" description="In dbSNP:rs34182094." evidence="27">
    <original>A</original>
    <variation>T</variation>
    <location>
      <position position="178"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_018148" description="In dbSNP:rs2076101." evidence="27">
    <original>V</original>
    <variation>I</variation>
    <location>
      <position position="231"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_025059" description="In dbSNP:rs12157816." evidence="27">
    <original>Y</original>
    <variation>C</variation>
    <location>
      <position position="307"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Reduced but not abolished antiviral activity." evidence="10">
    <original>H</original>
    <variation>C</variation>
    <location>
      <position position="65"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Nearly abolished antiviral activity; when associated with R-249." evidence="10">
    <original>H</original>
    <variation>R</variation>
    <location>
      <position position="65"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Decrease in cytidine deaminase and antiviral activity; when associated with A-251." evidence="9">
    <original>E</original>
    <variation>A</variation>
    <location>
      <position position="67"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="No effect on cytidine deaminase and antiviral activity." evidence="9">
    <original>E</original>
    <variation>A</variation>
    <location>
      <position position="67"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Reduced but not abolished antiviral activity. Nearly abolished antiviral activity; when associated with Q-251." evidence="10">
    <original>E</original>
    <variation>Q</variation>
    <location>
      <position position="67"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Reduced but not abolished antiviral activity. Nearly abolished antiviral activity; when associated with Q-280." evidence="10">
    <location>
      <position position="96"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Reduced but not abolished antiviral activityy. Nearly abolished antiviral activity; when associated with S-283." evidence="10">
    <original>C</original>
    <variation>S</variation>
    <location>
      <position position="99"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Reduced but not abolished antiviral activity." evidence="10">
    <original>H</original>
    <variation>C</variation>
    <location>
      <position position="249"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Nearly abolished antiviral activity; when associated with R-65." evidence="10">
    <original>H</original>
    <variation>R</variation>
    <location>
      <position position="249"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Decrease in cytidine deaminase and antiviral activity." evidence="9">
    <original>E</original>
    <variation>A</variation>
    <location>
      <position position="251"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Decrease in cytidine deaminase and antiviral activity; when associated with A-67." evidence="9">
    <original>E</original>
    <variation>A</variation>
    <location>
      <position position="251"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Remains able to bind Vif." evidence="21">
    <original>E</original>
    <variation>Q</variation>
    <location>
      <position position="251"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Reduced but not abolished antiviral activity. Nearly abolished antiviral activity; when associated with Q-67." evidence="10">
    <location>
      <position position="251"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Resistant to HIV-1 Vif and reduces Vif binding but is still efficiently incorporated into the virion." evidence="21">
    <original>L</original>
    <variation>D</variation>
    <location>
      <position position="255"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Resistant to HIV-1 Vif and reduces Vif binding but is still efficiently incorporated into the virion." evidence="21">
    <original>F</original>
    <variation>A</variation>
    <location>
      <position position="258"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Resistant to HIV-1 Vif and reduces Vif binding but is still efficiently incorporated into the virion." evidence="21">
    <original>C</original>
    <variation>K</variation>
    <location>
      <position position="259"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Does not affect interaction with APOBEC3G." evidence="25">
    <original>DD</original>
    <variation>RR</variation>
    <location>
      <begin position="260"/>
      <end position="261"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Resistant to HIV-1 Vif and abolishes Vif binding but is still efficiently incorporated into the virion." evidence="21">
    <original>IL</original>
    <variation>AA</variation>
    <location>
      <begin position="262"/>
      <end position="263"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Resistant to HIV-1 Vif and reduces Vif binding but is still efficiently incorporated into the virion." evidence="21">
    <original>S</original>
    <variation>D</variation>
    <location>
      <position position="264"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Impaired interaction with HIV-1 Vif protein." evidence="25">
    <original>P</original>
    <variation>A</variation>
    <location>
      <position position="265"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Resistant to HIV-1 Vif and reduces Vif binding but is still efficiently incorporated into the virion." evidence="21">
    <original>Y</original>
    <variation>A</variation>
    <location>
      <position position="269"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Reduced but not abolished antiviral activity. Nearly abolished antiviral activity; when associated with Q-96." evidence="10">
    <original>C</original>
    <variation>S</variation>
    <location>
      <position position="280"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Reduced but not abolished antiviral activity. Nearly abolished antiviral activity; when associated with S-99." evidence="10">
    <original>C</original>
    <variation>S</variation>
    <location>
      <position position="283"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Abolished interaction with HIV-1 Vif protein. Resistant to HIV-1 Vif and reduces Vif binding but is still efficiently incorporated into the virion." evidence="21 25">
    <original>E</original>
    <variation>K</variation>
    <location>
      <position position="289"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Resistant to HIV-1 Vif and reduces Vif binding but is still efficiently incorporated into the virion." evidence="21">
    <original>F</original>
    <variation>K</variation>
    <location>
      <position position="290"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Abolished interaction with HIV-1 Vif protein." evidence="25">
    <original>R</original>
    <variation>D</variation>
    <location>
      <position position="293"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Resistant to HIV-1 Vif, reduces Vif binding and abolishes incorporation into the virion." evidence="21">
    <original>H</original>
    <variation>D</variation>
    <location>
      <position position="294"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Resistant to HIV-1 Vif and reduces Vif binding." evidence="21">
    <original>E</original>
    <variation>K</variation>
    <variation>A</variation>
    <location>
      <position position="324"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Abolished interaction with HIV-1 Vif protein." evidence="25">
    <original>E</original>
    <variation>R</variation>
    <location>
      <position position="324"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Does not affect interaction with HIV-1 Vif protein." evidence="25">
    <original>D</original>
    <variation>R</variation>
    <location>
      <position position="347"/>
    </location>
  </feature>
  <feature type="helix" evidence="38">
    <location>
      <begin position="197"/>
      <end position="204"/>
    </location>
  </feature>
  <feature type="helix" evidence="38">
    <location>
      <begin position="208"/>
      <end position="212"/>
    </location>
  </feature>
  <feature type="strand" evidence="38">
    <location>
      <begin position="217"/>
      <end position="226"/>
    </location>
  </feature>
  <feature type="strand" evidence="38">
    <location>
      <begin position="232"/>
      <end position="239"/>
    </location>
  </feature>
  <feature type="turn" evidence="39">
    <location>
      <begin position="244"/>
      <end position="246"/>
    </location>
  </feature>
  <feature type="helix" evidence="38">
    <location>
      <begin position="250"/>
      <end position="261"/>
    </location>
  </feature>
  <feature type="strand" evidence="38">
    <location>
      <begin position="267"/>
      <end position="277"/>
    </location>
  </feature>
  <feature type="helix" evidence="38">
    <location>
      <begin position="281"/>
      <end position="293"/>
    </location>
  </feature>
  <feature type="strand" evidence="38">
    <location>
      <begin position="297"/>
      <end position="305"/>
    </location>
  </feature>
  <feature type="turn" evidence="39">
    <location>
      <begin position="307"/>
      <end position="310"/>
    </location>
  </feature>
  <feature type="helix" evidence="38">
    <location>
      <begin position="312"/>
      <end position="323"/>
    </location>
  </feature>
  <feature type="strand" evidence="38">
    <location>
      <begin position="327"/>
      <end position="330"/>
    </location>
  </feature>
  <feature type="helix" evidence="38">
    <location>
      <begin position="333"/>
      <end position="343"/>
    </location>
  </feature>
  <feature type="helix" evidence="38">
    <location>
      <begin position="357"/>
      <end position="372"/>
    </location>
  </feature>
  <evidence type="ECO:0000255" key="1">
    <source>
      <dbReference type="PROSITE-ProRule" id="PRU01083"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="2">
    <source>
      <dbReference type="PubMed" id="11863358"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="3">
    <source>
      <dbReference type="PubMed" id="15141007"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="4">
    <source>
      <dbReference type="PubMed" id="15152192"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="5">
    <source>
      <dbReference type="PubMed" id="15489334"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="6">
    <source>
      <dbReference type="PubMed" id="16378963"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="7">
    <source>
      <dbReference type="PubMed" id="16527742"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="8">
    <source>
      <dbReference type="PubMed" id="16699599"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="9">
    <source>
      <dbReference type="PubMed" id="17020885"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="10">
    <source>
      <dbReference type="PubMed" id="17121840"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="11">
    <source>
      <dbReference type="PubMed" id="19458006"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="12">
    <source>
      <dbReference type="PubMed" id="20062055"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="13">
    <source>
      <dbReference type="PubMed" id="20219927"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="14">
    <source>
      <dbReference type="PubMed" id="20308164"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="15">
    <source>
      <dbReference type="PubMed" id="20335265"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="16">
    <source>
      <dbReference type="PubMed" id="21496894"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="17">
    <source>
      <dbReference type="PubMed" id="21835787"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="18">
    <source>
      <dbReference type="PubMed" id="22190037"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="19">
    <source>
      <dbReference type="PubMed" id="22807680"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="20">
    <source>
      <dbReference type="PubMed" id="22915799"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="21">
    <source>
      <dbReference type="PubMed" id="23001005"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="22">
    <source>
      <dbReference type="PubMed" id="23097438"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="23">
    <source>
      <dbReference type="PubMed" id="23152537"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="24">
    <source>
      <dbReference type="PubMed" id="27139641"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="25">
    <source>
      <dbReference type="PubMed" id="31792451"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="26">
    <source>
      <dbReference type="PubMed" id="34774569"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="27">
    <source ref="2"/>
  </evidence>
  <evidence type="ECO:0000303" key="28">
    <source>
      <dbReference type="PubMed" id="15141007"/>
    </source>
  </evidence>
  <evidence type="ECO:0000303" key="29">
    <source>
      <dbReference type="PubMed" id="15461802"/>
    </source>
  </evidence>
  <evidence type="ECO:0000303" key="30">
    <source>
      <dbReference type="PubMed" id="15489334"/>
    </source>
  </evidence>
  <evidence type="ECO:0000303" key="31">
    <source>
      <dbReference type="PubMed" id="17121840"/>
    </source>
  </evidence>
  <evidence type="ECO:0000305" key="32"/>
  <evidence type="ECO:0000305" key="33">
    <source>
      <dbReference type="PubMed" id="23318957"/>
    </source>
  </evidence>
  <evidence type="ECO:0000312" key="34">
    <source>
      <dbReference type="HGNC" id="HGNC:17356"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="35">
    <source>
      <dbReference type="PDB" id="5HX4"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="36">
    <source>
      <dbReference type="PDB" id="5HX5"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="37">
    <source>
      <dbReference type="PDB" id="6NIL"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="38">
    <source>
      <dbReference type="PDB" id="5HX4"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="39">
    <source>
      <dbReference type="PDB" id="5ZVB"/>
    </source>
  </evidence>
  <sequence length="373" mass="45020" checksum="AF1A0E13830695F4" modified="2007-10-23" version="3">MKPHFRNTVERMYRDTFSYNFYNRPILSRRNTVWLCYEVKTKGPSRPRLDAKIFRGQVYSQPEHHAEMCFLSWFCGNQLPAYKCFQITWFVSWTPCPDCVAKLAEFLAEHPNVTLTISAARLYYYWERDYRRALCRLSQAGARVKIMDDEEFAYCWENFVYSEGQPFMPWYKFDDNYAFLHRTLKEILRNPMEAMYPHIFYFHFKNLRKAYGRNESWLCFTMEVVKHHSPVSWKRGVFRNQVDPETHCHAERCFLSWFCDDILSPNTNYEVTWYTSWSPCPECAGEVAEFLARHSNVNLTIFTARLYYFWDTDYQEGLRSLSQEGASVEIMGYKDFKYCWENFVYNDDEPFKPWKGLKYNFLFLDSKLQEILE</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>